Originally developed to manage type 2 diabetes, GLP-1 medications are now reshaping how we think about weight loss, appetite control, and metabolic health
The purpose of this review is to (1) detail the renal and cardiovascular mechanisms of incretin-based therapies, (2) summarize the clinical evidence from completed and ongoing CVOTs, (3) discuss emerging agents such as the dual GLP-1/GIP agonist tirzepatide, and (4) highlight remaining knowledge gaps as the therapeutic paradigm shifts from glucose-centric to cardiorenal-centric care
No, glutathione doesn't permanently lighten skin
They're FDA-approved
These GLP-1 analogs affect glucose-dependent insulinotropic polypeptide receptors and glucagon receptors, in addition to GLP-1R and are expected to exhibit stronger anti-obesity effects than that of semaglutide [21, 22]
If you have flexibility, it may be wise to wait until your baby is at least 7 months old and waiting until 912 months may be even safer
